O	O	0	9	Tolerance	Tolerance	B-NP	NN	O	4	SUB	O
O	O	10	12	to	to	B-PP	TO	O	1	NMOD	O
O	O	13	31	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	2	PMOD	O
O	O	32	40	involves	involve	B-VP	VBZ	O	0	ROOT	O
O	O	41	53	mobilization	mobilization	B-NP	NN	O	4	OBJ	O
O	O	54	56	of	of	B-PP	IN	O	5	NMOD	O
T11	B-Entity	57	64	nuclear	nuclear	B-NP	JJ	B-protein	10	NMOD	B-protein
T11	I-Entity	65	71	factor	factor	I-NP	NN	I-protein	10	NMOD	I-protein
T11	I-Entity	72	77	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T11	I-Entity	78	79	B	B	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	80	84	with	with	B-PP	IN	O	5	NMOD	O
O	O	85	97	predominance	predominance	B-NP	NN	O	11	PMOD	O
O	O	98	100	of	of	B-PP	IN	O	12	NMOD	O
T1	B-Protein	101	104	p50	p50	B-NP	NN	B-protein	15	NMOD	B-protein
T12	B-Entity	105	115	homodimers	homodimer	I-NP	NNS	I-protein	13	PMOD	I-protein
O	O	115	116	.	.	O	.	O	4	P	O

O	O	118	129	Stimulation	Stimulation	B-NP	NN	O	16	SUB	O
O	O	130	132	of	of	B-PP	IN	O	1	NMOD	O
O	O	133	136	the	the	B-NP	DT	O	7	NMOD	O
O	O	137	142	human	human	I-NP	JJ	B-cell_line	7	NMOD	B-cell_line
O	O	143	152	monocytic	monocytic	I-NP	JJ	I-cell_line	7	NMOD	I-cell_line
O	O	153	157	cell	cell	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	158	162	line	line	I-NP	NN	I-cell_line	9	NMOD	I-cell_line
O	O	163	167	Mono	Mono	I-NP	NN	B-cell_line	9	NMOD	B-cell_line
O	O	168	171	Mac	Mac	I-NP	NN	I-cell_line	2	PMOD	I-cell_line
O	O	172	173	6	6	I-NP	CD	I-cell_line	9	NMOD	I-cell_line
O	O	174	178	with	with	B-PP	IN	O	1	NMOD	O
O	O	179	197	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	11	PMOD	O
O	O	198	199	(	(	O	(	O	15	DEP	O
O	O	199	202	LPS	LPS	B-NP	NN	O	15	DEP	O
O	O	202	203	)	)	O	)	O	12	NMOD	O
O	O	204	209	leads	lead	B-VP	VBZ	O	0	ROOT	O
O	O	210	212	to	to	B-PP	TO	O	16	VMOD	O
O	O	213	218	rapid	rapid	B-NP	JJ	O	20	AMOD	O
O	O	219	222	and	and	I-NP	CC	O	20	AMOD	O
O	O	223	232	transient	transient	I-NP	JJ	O	21	NMOD	O
O	O	233	243	expression	expression	I-NP	NN	O	17	PMOD	O
O	O	244	246	of	of	B-PP	IN	O	21	NMOD	O
O	O	247	256	cytokines	cytokine	B-NP	NNS	B-protein	22	PMOD	B-protein
O	O	257	261	like	like	B-PP	IN	O	21	NMOD	O
O	O	262	267	tumor	tumor	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	268	276	necrosis	necrosis	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	277	283	factor	factor	I-NP	NN	I-protein	24	PMOD	I-protein
O	O	284	285	(	(	O	(	O	30	DEP	O
O	O	285	288	TNF	TNF	B-NP	NN	B-protein	30	DEP	B-protein
O	O	288	289	)	)	O	)	O	27	NMOD	O
O	O	289	290	.	.	O	.	O	16	P	O

O	O	291	295	When	When	B-ADVP	WRB	O	51	VMOD	O
O	O	296	300	such	such	B-NP	JJ	O	3	NMOD	O
O	O	301	306	cells	cell	I-NP	NNS	O	4	SUB	O
O	O	307	310	are	be	B-VP	VBP	O	1	SBAR	O
O	O	311	322	precultured	preculture	I-VP	VBN	O	4	VC	O
O	O	323	326	for	for	B-PP	IN	O	5	VMOD	O
O	O	327	328	2	2	B-NP	CD	O	8	NMOD	O
O	O	329	333	days	day	I-NP	NNS	O	6	PMOD	O
O	O	334	338	with	with	B-PP	IN	O	5	VMOD	O
O	O	339	340	a	a	B-NP	DT	O	12	NMOD	O
O	O	341	344	low	low	I-NP	JJ	O	12	NMOD	O
O	O	345	349	dose	dose	I-NP	NN	O	9	PMOD	O
O	O	350	352	of	of	B-PP	IN	O	12	NMOD	O
O	O	353	356	LPS	LPS	B-NP	NN	O	13	PMOD	O
O	O	357	358	(	(	O	(	O	20	DEP	O
O	O	358	360	20	20	B-NP	CD	O	19	NMOD	O
O	O	361	363	ng	ng	I-NP	NN	O	19	NMOD	O
O	O	363	364	/	/	B-NP	SYM	O	19	NMOD	O
O	O	364	366	ml	ml	I-NP	NN	O	20	DEP	O
O	O	366	367	)	)	O	)	O	12	NMOD	O
O	O	368	376	followed	follow	B-VP	VBN	O	4	VMOD	O
O	O	377	379	by	by	B-PP	IN	O	21	VMOD	O
O	O	380	391	stimulation	stimulation	B-NP	NN	O	22	PMOD	O
O	O	392	396	with	with	B-PP	IN	O	23	NMOD	O
O	O	397	398	a	a	B-NP	DT	O	27	NMOD	O
O	O	399	403	high	high	I-NP	JJ	O	27	NMOD	O
O	O	404	408	dose	dose	I-NP	NN	O	24	PMOD	O
O	O	409	411	of	of	B-PP	IN	O	27	NMOD	O
O	O	412	415	LPS	LPS	B-NP	NN	O	28	PMOD	O
O	O	416	417	(	(	O	(	O	35	DEP	O
O	O	417	418	1	1	B-NP	CD	O	34	NMOD	O
O	O	419	428	microgram	microgram	I-NP	NN	O	34	NMOD	O
O	O	428	429	/	/	B-NP	SYM	O	34	P	O
O	O	429	431	ml	ml	I-NP	NN	O	35	DEP	O
O	O	431	432	)	)	O	)	O	27	NMOD	O
O	O	432	433	,	,	O	,	O	51	P	O
O	O	434	444	expression	expression	B-NP	NN	O	42	SUB	O
O	O	445	447	of	of	B-PP	IN	O	37	NMOD	O
O	O	448	451	the	the	B-NP	DT	O	41	NMOD	O
T13	B-Entity	452	455	TNF	TNF	I-NP	NN	B-DNA	41	NMOD	B-DNA
T13	I-Entity	456	460	gene	gene	I-NP	NN	I-DNA	38	PMOD	I-DNA
O	O	461	463	is	be	B-VP	VBZ	O	51	VMOD	O
O	O	464	471	minimal	minimal	B-ADJP	JJ	O	42	PRD	O
O	O	471	472	,	,	O	,	O	51	P	O
O	O	473	474	i	i	B-NP	NN	O	47	NMOD	O
O	O	474	475	.	.	I-NP	.	O	45	P	O
O	O	475	476	e	e	I-NP	NN	O	51	SUB	O
O	O	476	477	.	.	O	.	O	47	P	O
O	O	478	481	the	the	B-NP	DT	O	50	NMOD	O
O	O	482	487	cells	cell	I-NP	NNS	O	51	SUB	O
O	O	488	491	are	be	B-VP	VBP	O	0	ROOT	O
O	O	492	500	tolerant	tolerant	B-ADJP	JJ	O	51	PRD	O
O	O	500	501	.	.	O	.	O	51	P	O

O	O	502	504	In	In	B-PP	IN	O	11	VMOD	O
O	O	505	512	nuclear	nuclear	B-NP	JJ	O	3	NMOD	O
O	O	513	516	run	run	I-NP	NN	O	1	PMOD	O
O	O	516	517	-	-	B-ADVP	HYPH	O	1	PMOD	O
O	O	517	519	on	on	B-PP	IN	O	1	PMOD	O
O	O	520	528	analysis	analysis	B-NP	NN	O	5	PMOD	O
O	O	528	529	,	,	O	,	O	11	P	O
O	O	530	534	such	such	B-NP	JJ	O	10	NMOD	O
O	O	535	543	tolerant	tolerant	I-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	544	549	cells	cell	I-NP	NNS	I-cell_type	11	SUB	I-cell_type
O	O	550	554	show	show	B-VP	VBP	O	0	ROOT	O
O	O	555	559	only	only	B-NP	RB	O	15	NMOD	O
O	O	560	561	a	a	I-NP	DT	O	15	NMOD	O
O	O	562	565	low	low	I-NP	JJ	O	15	NMOD	O
O	O	566	572	degree	degree	I-NP	NN	O	11	OBJ	O
O	O	573	575	of	of	B-PP	IN	O	15	NMOD	O
O	O	576	589	transcription	transcription	B-NP	NN	O	16	PMOD	O
O	O	589	590	,	,	O	,	O	11	P	O
O	O	591	601	indicating	indicate	B-VP	VBG	O	11	VMOD	O
O	O	602	606	that	that	B-SBAR	IN	O	19	VMOD	O
O	O	607	616	tolerance	tolerance	B-NP	NN	O	22	SUB	O
O	O	617	625	operates	operate	B-VP	VBZ	O	20	SBAR	O
O	O	626	628	at	at	B-PP	IN	O	22	VMOD	O
O	O	629	631	or	or	O	CC	O	23	DEP	O
O	O	632	640	upstream	upstream	B-ADVP	RB	O	23	DEP	O
O	O	641	643	of	of	B-PP	IN	O	25	AMOD	O
O	O	644	647	the	the	B-NP	DT	O	29	NMOD	O
O	O	648	661	transcription	transcription	I-NP	NN	O	29	NMOD	O
O	O	662	667	level	level	I-NP	NN	O	26	PMOD	O
O	O	667	668	.	.	O	.	O	11	P	O

O	O	669	672	The	The	B-NP	DT	O	4	NMOD	O
T2	B-Protein	673	677	CD14	CD14	I-NP	NN	B-protein	4	NMOD	B-protein
O	O	678	681	LPS	LPS	I-NP	NN	O	4	NMOD	O
O	O	682	690	receptor	receptor	I-NP	NN	O	5	SUB	O
O	O	691	693	is	be	B-VP	VBZ	O	24	VMOD	O
O	O	693	694	,	,	O	,	O	5	P	O
O	O	695	702	however	however	B-ADVP	RB	O	5	VMOD	O
O	O	702	703	,	,	O	,	O	5	P	O
O	O	704	706	up	up	B-ADVP	RB	O	10	VMOD	O
O	O	706	707	-	-	B-VP	HYPH	O	5	VMOD	O
O	O	707	716	regulated	regulate	I-VP	VBN	O	10	VC	O
O	O	717	718	(	(	O	(	O	11	VMOD	O
O	O	718	721	not	not	O	RB	O	11	VMOD	O
O	O	722	726	down	down	B-VP	RB	O	15	VMOD	O
O	O	726	727	-	-	I-VP	HYPH	O	11	P	O
O	O	727	736	regulated	regulate	I-VP	VBN	O	17	DEP	O
O	O	736	737	)	)	O	)	O	11	VMOD	O
O	O	738	740	in	in	B-PP	IN	O	11	VMOD	O
O	O	741	749	tolerant	tolerant	B-NP	JJ	B-cell_line	20	NMOD	B-cell_line
O	O	750	755	cells	cell	I-NP	NNS	I-cell_line	18	PMOD	I-cell_line
O	O	755	756	,	,	O	,	O	24	P	O
O	O	757	760	and	and	O	CC	O	23	NMOD	O
O	O	761	764	LPS	LPS	B-NP	NN	O	24	SUB	O
O	O	765	768	can	can	B-VP	MD	O	0	ROOT	O
O	O	768	769	,	,	O	,	O	24	P	O
O	O	770	772	in	in	B-PP	IN	O	24	VMOD	O
O	O	773	777	fact	fact	B-NP	NN	O	26	PMOD	O
O	O	777	778	,	,	O	,	O	24	P	O
O	O	779	784	still	still	B-ADVP	RB	O	24	VMOD	O
O	O	785	789	lead	lead	B-VP	VB	O	24	VC	O
O	O	790	792	to	to	B-PP	TO	O	30	VMOD	O
O	O	793	803	activation	activation	B-NP	NN	O	31	PMOD	O
O	O	804	806	of	of	B-PP	IN	O	32	NMOD	O
O	O	807	815	tolerant	tolerant	B-NP	JJ	B-cell_type	35	NMOD	B-cell_type
O	O	816	821	cells	cell	I-NP	NNS	I-cell_type	33	PMOD	I-cell_type
O	O	822	824	as	as	B-SBAR	IN	O	24	VMOD	O
O	O	825	834	evidenced	evidence	B-VP	VBN	O	36	SBAR	O
O	O	835	837	by	by	B-PP	IN	O	37	VMOD	O
O	O	838	850	mobilization	mobilization	B-NP	NN	O	38	PMOD	O
O	O	851	853	of	of	B-PP	IN	O	39	NMOD	O
O	O	854	857	the	the	B-NP	DT	O	47	NMOD	O
O	O	858	871	transcription	transcription	I-NP	NN	B-protein	43	NMOD	B-protein
O	O	872	878	factor	factor	I-NP	NN	I-protein	47	NMOD	I-protein
T14	B-Entity	879	886	nuclear	nuclear	B-NP	JJ	B-protein	47	NMOD	B-protein
T14	I-Entity	887	893	factor	factor	I-NP	NN	I-protein	47	NMOD	I-protein
T14	I-Entity	894	899	kappa	kappa	I-NP	NN	I-protein	47	NMOD	I-protein
T14	I-Entity	900	901	B	B	I-NP	NN	I-protein	40	PMOD	I-protein
O	O	902	903	(	(	O	(	O	53	DEP	O
T15	B-Entity	903	905	NF	NF	B-NP	NN	B-protein	52	NMOD	B-protein
T15	I-Entity	905	906	-	-	B-NP	HYPH	I-protein	52	NMOD	I-protein
T15	I-Entity	906	911	kappa	kappa	I-NP	NN	I-protein	52	NMOD	I-protein
T15	I-Entity	912	913	B	B	I-NP	NN	I-protein	53	DEP	I-protein
O	O	913	914	)	)	O	)	O	47	NMOD	O
O	O	914	915	.	.	O	.	O	24	P	O

O	O	916	926	Resolution	Resolution	B-NP	NN	O	13	SUB	O
O	O	927	929	of	of	B-PP	IN	O	1	NMOD	O
O	O	930	933	the	the	B-NP	DT	O	8	NMOD	O
T16	B-Entity	934	936	NF	NF	I-NP	NN	B-protein	8	NMOD	B-protein
T16	I-Entity	936	937	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T16	I-Entity	937	942	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T16	I-Entity	943	944	B	B	I-NP	NN	I-protein	8	NMOD	I-protein
T16	I-Entity	945	952	complex	complex	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	953	955	in	in	B-PP	IN	O	1	NMOD	O
O	O	956	959	gel	gel	B-NP	NN	O	12	NMOD	O
O	O	960	965	shift	shift	I-NP	NN	O	12	NMOD	O
O	O	966	974	analysis	analysis	I-NP	NN	O	9	PMOD	O
O	O	975	980	shows	show	B-VP	VBZ	O	0	ROOT	O
O	O	981	985	that	that	B-SBAR	IN	O	13	VMOD	O
O	O	986	989	the	the	B-NP	DT	O	17	NMOD	O
O	O	990	997	binding	bind	I-NP	VBG	B-protein	17	NMOD	B-protein
O	O	998	1005	protein	protein	I-NP	NN	I-protein	27	SUB	I-protein
O	O	1005	1006	,	,	O	,	O	17	P	O
O	O	1007	1016	mobilized	mobilize	B-VP	VBN	O	17	NMOD	O
O	O	1017	1019	in	in	B-PP	IN	O	19	VMOD	O
O	O	1020	1025	naive	naive	B-NP	JJ	B-cell_line	25	NMOD	B-cell_line
O	O	1026	1030	Mono	Mono	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	1031	1034	Mac	Mac	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	1035	1036	6	6	B-NP	CD	I-cell_line	25	NMOD	I-cell_line
O	O	1037	1042	cells	cell	I-NP	NNS	I-cell_line	20	PMOD	I-cell_line
O	O	1042	1043	,	,	O	,	O	17	P	O
O	O	1044	1052	consists	consist	B-VP	VBZ	O	14	SBAR	O
O	O	1053	1059	mainly	mainly	B-ADVP	RB	O	27	VMOD	O
O	O	1060	1062	of	of	B-PP	IN	O	27	VMOD	O
T3	B-Protein	1063	1066	p50	p50	B-NP	NN	B-protein	33	NMOD	B-protein
O	O	1066	1067	-	-	B-NP	HYPH	I-protein	33	NMOD	I-protein
T4	B-Protein	1067	1070	p65	p65	I-NP	NN	I-protein	33	NMOD	I-protein
T17	B-Entity	1071	1083	heterodimers	heterodimer	I-NP	NNS	I-protein	29	PMOD	I-protein
O	O	1083	1084	,	,	O	,	O	27	P	O
O	O	1085	1090	while	while	B-SBAR	IN	O	27	VMOD	O
O	O	1091	1093	in	in	B-PP	IN	O	43	VMOD	O
O	O	1094	1102	tolerant	tolerant	B-NP	JJ	B-cell_line	38	NMOD	B-cell_line
O	O	1103	1108	cells	cell	I-NP	NNS	I-cell_line	36	PMOD	I-cell_line
O	O	1108	1109	,	,	O	,	O	43	P	O
O	O	1110	1113	the	the	B-NP	DT	O	42	NMOD	O
T5	B-Protein	1114	1117	p50	p50	I-NP	NN	B-protein	42	NMOD	B-protein
T18	B-Entity	1118	1127	homodimer	homodimer	I-NP	NN	I-protein	43	SUB	I-protein
O	O	1128	1130	is	be	B-VP	VBZ	O	35	SBAR	O
O	O	1131	1142	predominant	predominant	B-ADJP	JJ	O	43	PRD	O
O	O	1142	1143	.	.	O	.	O	13	P	O

O	O	1144	1148	This	This	B-NP	DT	O	2	NMOD	O
O	O	1149	1157	increase	increase	I-NP	NN	O	6	SUB	O
O	O	1158	1160	in	in	B-PP	IN	O	2	NMOD	O
T6	B-Protein	1161	1164	p50	p50	B-NP	NN	B-protein	5	NMOD	B-protein
T19	B-Entity	1165	1175	homodimers	homodimer	I-NP	NNS	I-protein	3	PMOD	I-protein
O	O	1176	1185	coincides	coincide	B-VP	VBZ	O	0	ROOT	O
O	O	1186	1190	with	with	B-PP	IN	O	6	VMOD	O
O	O	1191	1193	an	an	B-NP	DT	O	9	NMOD	O
O	O	1194	1202	increase	increase	I-NP	NN	O	7	PMOD	O
O	O	1203	1205	in	in	B-PP	IN	O	9	NMOD	O
T7	B-Protein	1206	1210	p105	p105	B-NP	NN	B-RNA	12	NMOD	B-RNA
O	O	1211	1215	mRNA	mRNA	I-NP	NN	I-RNA	10	PMOD	I-RNA
O	O	1215	1216	,	,	O	,	O	6	P	O
O	O	1217	1227	suggestive	suggestive	B-ADJP	JJ	O	6	VMOD	O
O	O	1228	1230	of	of	B-PP	IN	O	14	AMOD	O
O	O	1231	1232	a	a	B-NP	DT	O	20	NMOD	O
O	O	1233	1248	transcriptional	transcriptional	I-NP	JJ	O	20	NMOD	O
O	O	1249	1251	up	up	B-ADVP	RB	O	20	NMOD	O
O	O	1251	1252	-	-	O	HYPH	O	18	AMOD	O
O	O	1252	1262	regulation	regulation	B-NP	NN	O	15	PMOD	O
O	O	1263	1265	of	of	B-PP	IN	O	20	NMOD	O
T8	B-Protein	1266	1269	p50	p50	B-NP	NN	B-protein	21	PMOD	B-protein
O	O	1269	1270	.	.	O	.	O	6	P	O

O	O	1271	1279	Reporter	Reporter	B-NP	NN	B-DNA	3	NMOD	B-DNA
O	O	1280	1284	gene	gene	I-NP	NN	I-DNA	3	NMOD	I-DNA
O	O	1285	1293	analysis	analysis	I-NP	NN	O	4	SUB	O
O	O	1294	1301	reveals	reveal	B-VP	VBZ	O	0	ROOT	O
O	O	1302	1306	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	1307	1310	the	the	B-NP	DT	O	11	NMOD	O
T20	B-Entity	1311	1313	NF	NF	I-NP	NN	B-protein	11	NMOD	B-protein
T20	I-Entity	1313	1314	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T20	I-Entity	1314	1319	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T20	I-Entity	1320	1321	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
T20	I-Entity	1322	1329	complex	complex	I-NP	NN	I-protein	16	SUB	I-protein
O	O	1330	1339	mobilized	mobilize	B-VP	VBN	O	11	NMOD	O
O	O	1340	1342	in	in	B-PP	IN	O	12	VMOD	O
O	O	1343	1351	tolerant	tolerant	B-NP	JJ	B-cell_line	15	NMOD	B-cell_line
O	O	1352	1357	cells	cell	I-NP	NNS	I-cell_line	13	PMOD	I-cell_line
O	O	1358	1360	is	be	B-VP	VBZ	O	5	SBAR	O
O	O	1361	1373	functionally	functionally	B-ADJP	RB	O	18	AMOD	O
O	O	1374	1382	inactive	inactive	I-ADJP	JJ	O	16	PRD	O
O	O	1383	1385	in	in	B-PP	IN	O	18	AMOD	O
O	O	1386	1390	that	that	B-NP	IN	O	19	PMOD	O
T21	B-Entity	1391	1393	NF	NF	I-NP	NN	B-protein	24	NMOD	B-protein
T21	I-Entity	1393	1394	-	-	I-NP	HYPH	I-protein	24	P	I-protein
T21	I-Entity	1394	1399	kappa	kappa	B-NP	NN	I-protein	24	NMOD	I-protein
T21	I-Entity	1400	1401	B	B	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1401	1402	-	-	B-NP	HYPH	O	28	P	O
O	O	1402	1411	dependent	dependent	I-NP	JJ	O	28	NMOD	O
O	O	1412	1422	luciferase	luciferase	I-NP	NN	B-DNA	28	NMOD	B-DNA
O	O	1423	1433	constructs	construct	I-NP	NNS	I-DNA	44	SUB	I-DNA
O	O	1434	1444	containing	contain	B-VP	VBG	O	28	NMOD	O
O	O	1445	1448	the	the	B-NP	DT	O	36	NMOD	O
T22	B-Entity	1449	1454	human	human	I-NP	JJ	B-DNA	36	NMOD	B-DNA
T22	I-Entity	1455	1471	immunodeficiency	immunodeficiency	I-NP	NN	I-DNA	36	NMOD	I-DNA
T22	I-Entity	1472	1477	virus	virus	I-NP	NN	I-DNA	36	NMOD	I-DNA
T22	I-Entity	1478	1482	long	long	I-NP	JJ	I-DNA	36	NMOD	I-DNA
T22	I-Entity	1483	1491	terminal	terminal	I-NP	JJ	I-DNA	36	NMOD	I-DNA
T22	I-Entity	1492	1498	repeat	repeat	I-NP	NN	I-DNA	43	NMOD	I-DNA
O	O	1499	1501	or	or	O	CC	O	43	NMOD	O
O	O	1502	1505	the	the	B-NP	DT	O	43	NMOD	O
T23	B-Entity	1506	1509	TNF	TNF	I-NP	NN	B-DNA	43	NMOD	B-DNA
T23	I-Entity	1510	1511	5	5	I-NP	CD	I-DNA	43	NMOD	I-DNA
T23	I-Entity	1511	1512	'	'	I-NP	SYM	I-DNA	43	NMOD	I-DNA
T23	I-Entity	1512	1513	-	-	I-NP	HYPH	I-DNA	43	NMOD	I-DNA
T23	I-Entity	1513	1519	region	region	I-NP	NN	I-DNA	29	OBJ	I-DNA
O	O	1520	1524	show	show	B-VP	VBP	O	20	SBAR	O
O	O	1525	1529	only	only	B-NP	RB	O	47	NMOD	O
O	O	1530	1537	minimal	minimal	I-NP	JJ	O	47	NMOD	O
O	O	1538	1553	transactivation	transactivation	I-NP	NN	O	44	OBJ	O
O	O	1554	1559	after	after	B-PP	IN	O	44	VMOD	O
O	O	1560	1563	LPS	LPS	B-NP	NN	O	50	NMOD	O
O	O	1564	1575	stimulation	stimulation	I-NP	NN	O	48	PMOD	O
O	O	1575	1576	.	.	O	.	O	4	P	O

O	O	1577	1584	Similar	Similar	B-ADJP	JJ	O	22	VMOD	O
O	O	1585	1587	to	to	B-PP	TO	O	1	AMOD	O
O	O	1588	1592	Mono	Mono	B-NP	NN	B-cell_line	6	NMOD	B-cell_line
O	O	1593	1596	Mac	Mac	I-NP	NN	I-cell_line	6	NMOD	I-cell_line
O	O	1597	1598	6	6	B-NP	CD	I-cell_line	6	NMOD	I-cell_line
O	O	1599	1604	cells	cell	I-NP	NNS	I-cell_line	2	PMOD	I-cell_line
O	O	1604	1605	,	,	O	,	O	22	P	O
O	O	1606	1613	primary	primary	B-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	1614	1619	blood	blood	I-NP	NN	I-cell_type	10	NMOD	I-cell_type
O	O	1620	1629	monocytes	monocyte	I-NP	NNS	I-cell_type	22	SUB	I-cell_type
O	O	1629	1630	,	,	O	,	O	10	P	O
O	O	1631	1635	when	when	B-ADVP	WRB	O	22	VMOD	O
O	O	1636	1647	precultured	preculture	B-VP	VBN	O	12	SBAR	O
O	O	1648	1652	with	with	B-PP	IN	O	13	VMOD	O
O	O	1653	1654	a	a	B-NP	DT	O	17	NMOD	O
O	O	1655	1658	low	low	I-NP	JJ	O	17	NMOD	O
O	O	1659	1663	dose	dose	I-NP	NN	O	14	PMOD	O
O	O	1664	1666	of	of	B-PP	IN	O	17	NMOD	O
O	O	1667	1670	LPS	LPS	B-NP	NN	O	18	PMOD	O
O	O	1670	1671	,	,	O	,	O	22	P	O
O	O	1672	1676	also	also	B-ADVP	RB	O	22	VMOD	O
O	O	1677	1683	become	become	B-VP	VBP	O	0	ROOT	O
O	O	1684	1692	tolerant	tolerant	B-ADJP	JJ	O	22	PRD	O
O	O	1693	1696	and	and	O	CC	O	22	VMOD	O
O	O	1697	1704	produce	produce	B-VP	VBP	O	22	VMOD	O
O	O	1705	1711	little	little	B-NP	JJ	O	27	NMOD	O
O	O	1712	1715	TNF	TNF	I-NP	NN	B-protein	25	OBJ	B-protein
O	O	1716	1721	after	after	B-PP	IN	O	22	VMOD	O
O	O	1722	1725	LPS	LPS	B-NP	NN	O	30	NMOD	O
O	O	1726	1737	stimulation	stimulation	I-NP	NN	O	28	PMOD	O
O	O	1737	1738	.	.	O	.	O	22	P	O

O	O	1739	1742	The	The	B-NP	DT	O	4	NMOD	O
O	O	1743	1751	tolerant	tolerant	I-NP	JJ	B-cell_type	4	NMOD	B-cell_type
O	O	1752	1757	blood	blood	I-NP	NN	I-cell_type	4	NMOD	I-cell_type
O	O	1758	1767	monocytes	monocyte	I-NP	NNS	I-cell_type	13	SUB	I-cell_type
O	O	1768	1772	also	also	B-ADVP	RB	O	7	VMOD	O
O	O	1773	1775	up	up	B-ADVP	RB	O	7	VMOD	O
O	O	1775	1776	-	-	B-NP	HYPH	O	4	P	O
O	O	1776	1784	regulate	regulate	B-VP	VB	O	4	VMOD	O
T9	B-Protein	1785	1789	CD14	CD14	B-NP	NN	B-protein	8	OBJ	B-protein
O	O	1789	1790	,	,	O	,	O	13	P	O
O	O	1791	1794	and	and	O	CC	O	13	VMOD	O
O	O	1795	1799	they	they	B-NP	PRP	O	13	SUB	O
O	O	1800	1808	mobilize	mobilize	B-VP	VBP	O	0	ROOT	O
T24	B-Entity	1809	1811	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
T24	I-Entity	1811	1812	-	-	B-VP	HYPH	I-protein	17	NMOD	I-protein
T24	I-Entity	1812	1817	kappa	kappa	B-NP	NN	I-protein	17	NMOD	I-protein
T24	I-Entity	1818	1819	B	B	I-NP	NN	I-protein	13	OBJ	I-protein
O	O	1820	1824	with	with	B-PP	IN	O	13	VMOD	O
O	O	1825	1826	a	a	B-NP	DT	O	20	NMOD	O
O	O	1827	1839	predominance	predominance	I-NP	NN	O	18	PMOD	O
O	O	1840	1842	of	of	B-PP	IN	O	20	NMOD	O
T10	B-Protein	1843	1846	p50	p50	B-NP	NN	B-protein	23	NMOD	B-protein
T25	B-Entity	1847	1857	homodimers	homodimer	I-NP	NNS	I-protein	21	PMOD	I-protein
O	O	1857	1858	.	.	O	.	O	13	P	O

O	O	1859	1864	Taken	Take	B-VP	VBN	O	6	VMOD	O
O	O	1865	1873	together	together	B-ADVP	RB	O	1	VMOD	O
O	O	1873	1874	,	,	O	,	O	6	P	O
O	O	1875	1880	these	these	B-NP	DT	O	5	NMOD	O
O	O	1881	1888	results	result	I-NP	NNS	O	6	SUB	O
O	O	1889	1900	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	1901	1905	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	1906	1915	tolerance	tolerance	B-NP	NN	O	11	SUB	O
O	O	1916	1918	to	to	B-PP	TO	O	8	NMOD	O
O	O	1919	1922	LPS	LPS	B-NP	NN	O	9	PMOD	O
O	O	1923	1925	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	1926	1936	determined	determine	I-VP	VBN	O	11	VC	O
O	O	1937	1939	by	by	B-PP	IN	O	12	VMOD	O
O	O	1940	1944	post	post	B-NP	AFX	O	17	NMOD	O
O	O	1944	1945	-	-	I-NP	HYPH	O	17	P	O
O	O	1945	1953	receptor	receptor	I-NP	NN	O	17	NMOD	O
O	O	1954	1964	mechanisms	mechanism	I-NP	NNS	O	13	PMOD	O
O	O	1965	1969	that	that	B-NP	WDT	O	17	NMOD	O
O	O	1970	1977	involve	involve	B-VP	VBP	O	18	SBAR	O
O	O	1978	1980	an	an	B-NP	DT	O	22	NMOD	O
O	O	1981	1988	altered	altered	I-NP	JJ	O	22	NMOD	O
O	O	1989	2000	composition	composition	I-NP	NN	O	19	OBJ	O
O	O	2001	2003	of	of	B-PP	IN	O	22	NMOD	O
O	O	2004	2007	the	the	B-NP	DT	O	29	NMOD	O
T26	B-Entity	2008	2010	NF	NF	I-NP	NN	B-protein	29	NMOD	B-protein
T26	I-Entity	2010	2011	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
T26	I-Entity	2011	2016	kappa	kappa	I-NP	NN	I-protein	29	NMOD	I-protein
T26	I-Entity	2017	2018	B	B	I-NP	NN	I-protein	29	NMOD	I-protein
T26	I-Entity	2019	2026	complex	complex	I-NP	NN	I-protein	23	PMOD	I-protein
O	O	2026	2027	.	.	O	.	O	6	P	O
